Establishment Labs Holdings (ESTA) Cash from Financing Activities (2017 - 2026)

Establishment Labs Holdings' (ESTA) quarterly Cash from Financing Activities came in at -$864000.0 in Q1 2026, down 325.62% year-on-year from $382952.0 in Q1 2025, and down 114.27% quarter-over-quarter from $6.1 million in Q4 2025.

Establishment Labs Holdings (ESTA) Cash from Financing Activities (2017 - 2026) Analysis & Trends

Establishment Labs Holdings' Cash from Financing Activities history runs 10 years deep, the most recent figure standing at -$864000.0 for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 325.62% year-over-year to -$864000.0 in Q1 2026; TTM through Mar 2026 was $39.8 million, a 46.72% decrease from a year earlier, with the FY2025 full-year figure at $40.4 million, down 67.88% from the prior year.
  • Cash from Financing Activities declined to -$864000.0 in Q1 2026 per ESTA's latest filing, from $6.1 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $84.5 million in Q2 2023 and bottomed at -$864000.0 in Q1 2026.
  • The 5-year median for Cash from Financing Activities is $1.7 million (2022), against an average of $20.7 million.
  • Across the five-year window, Cash from Financing Activities surged 114501.54% in 2024 and sank 325.62% in 2026, its largest moves.
  • Year by year, Cash from Financing Activities stood at $25.0 million in 2022, then plunged by 99.74% to $65000.0 in 2023, then jumped by 114501.54% to $74.5 million in 2024, then plunged by 91.87% to $6.1 million in 2025, then slumped by 114.27% to -$864000.0 in 2026.
  • Per Business Quant, the three latest ESTA Cash from Financing Activities figures stand at -$864000.0 (Q1 2026), $6.1 million (Q4 2025), and $29.5 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn 17.31 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn -1.51 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn -888.00 Mn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn -260.00 Mn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn -451.20 Mn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn -25.00 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn -26.93 Mn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 21.00 Mn
9 Smith & Nephew 25.80 Bn 25.22 Bn - -
10 Establishment Labs Holdings 2.73 Bn 2.66 Bn 42.34 Mn -864,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -864,000.00
Mar 31, 2026 -864,000.00
Dec 31, 2025 6.05 Mn
Dec 31, 2025 6.05 Mn
Sep 30, 2025 29.45 Mn
Sep 30, 2025 29.45 Mn
Jun 30, 2025 5.13 Mn
Jun 30, 2025 5.13 Mn
Mar 31, 2025 -203,000.00
Mar 31, 2025 -203,000.00
Dec 31, 2024 74.49 Mn
Dec 31, 2024 74.49 Mn
Sep 30, 2024 -28,000.00
Sep 30, 2024 -28,000.00
Jun 30, 2024 389,000.00
Jun 30, 2024 389,000.00
Mar 31, 2024 51.04 Mn
Mar 31, 2024 51.04 Mn
Dec 31, 2023 65,000.00
Dec 31, 2023 65,000.00